S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet

Treace Medical Concepts (TMCI) Earnings Date, Estimates & Call Transcripts

$13.42
-0.02 (-0.15%)
(As of 03/1/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 13Estimated
Actual EPS
(Feb. 27)
-$0.10 Missed By -$0.01
Consensus EPS
(Feb. 27)
-$0.09
Skip Charts & View Estimated and Actual Earnings Data

TMCI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TMCI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Treace Medical Concepts Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.77) EPS
Next Year EPS Consensus Estimate: ($0.76) EPS

TMCI Earnings Date and Information

Treace Medical Concepts last issued its earnings results on February 27th, 2024. The reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.09) by $0.01. The firm earned $62.20 million during the quarter, compared to analysts' expectations of $60.56 million. Its quarterly revenue was up 24.9% compared to the same quarter last year. Treace Medical Concepts has generated ($0.81) earnings per share over the last year (($0.81) diluted earnings per share). Earnings for Treace Medical Concepts are expected to grow in the coming year, from ($0.77) to ($0.76) per share. Treace Medical Concepts has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off prior year's report dates.

Treace Medical Concepts Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/13/2024
Estimated)
------- 
2/27/2024Q4 2023($0.09)($0.10)($0.01)($0.10)$60.56 million$62.20 million    
11/9/2023Q3 2023($0.26)($0.28)($0.02)($0.28)$42.08 million$40.76 million    
8/8/2023Q2 2023($0.23)($0.20)+$0.03($0.20)$40.84 million$41.95 million    
5/8/2023Q1 2023($0.23)($0.23)-($0.23)$39.48 million$42.20 million
3/7/2023Q4 2022($0.13)($0.08)+$0.05($0.08)-$49.77 million    
11/8/2022Q3 2022($0.28)($0.22)+$0.06($0.22)$30.10 million$33.06 million  
8/9/2022Q2 2022($0.21)($0.23)($0.02)($0.15)$28.71 million$29.97 million
5/5/2022Q1 2022($0.20)($0.16)+$0.04($0.16)$26.18 million$29.05 million    
3/3/2022Q4 2021($0.01)($0.12)($0.11)($0.12)$33.27 million$33.44 million    
11/4/2021Q3 2021($0.12)($0.12)-($0.12)$21.06 million$21.62 million    
8/5/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$18.80 million$20.65 million  
5/24/2021Q1 2021($0.06)($0.07)($0.01)($0.07)$18.65 million$18.71 million  












Treace Medical Concepts Earnings - Frequently Asked Questions

When is Treace Medical Concepts's earnings date?

Treace Medical Concepts has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off last year's report dates. Learn more on TMCI's earnings history.

Did Treace Medical Concepts beat their earnings estimates last quarter?

In the previous quarter, Treace Medical Concepts (NASDAQ:TMCI) missed the analysts' consensus estimate of ($0.09) by $0.01 with a reported earnings per share (EPS) of ($0.10). Learn more on analysts' earnings estimate vs. TMCI's actual earnings.

How can I listen to Treace Medical Concepts's earnings conference call?

The conference call for Treace Medical Concepts's latest earnings report can be listened to online. Listen to Conference Call

How can I read Treace Medical Concepts's conference call transcript?

The conference call transcript for Treace Medical Concepts's latest earnings report can be read online. Read Transcript

How much revenue does Treace Medical Concepts generate each year?

Treace Medical Concepts (NASDAQ:TMCI) has a recorded annual revenue of $187.12 million.

How much profit does Treace Medical Concepts generate each year?

Treace Medical Concepts (NASDAQ:TMCI) has a recorded net income of -$42.81 million. TMCI has generated -$0.81 earnings per share over the last four quarters.

What is Treace Medical Concepts's EPS forecast for next year?

Treace Medical Concepts's earnings are expected to grow from ($0.77) per share to ($0.76) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:TMCI) was last updated on 3/3/2024 by MarketBeat.com Staff